HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James C M Ho Selected Research

Crizotinib

10/2018Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James C M Ho Research Topics

Disease

2Neoplasms (Cancer)
10/2020 - 11/2015
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2018 - 07/2003
2Lung Neoplasms (Lung Cancer)
11/2015 - 12/2002
1Anemia
10/2018
1Neutropenia
10/2018
1Diarrhea
10/2018
1Vision Disorders (Hemeralopia)
10/2018
1Leukopenia
10/2018
1Carcinoma (Carcinomatosis)
05/2016
1Asthma (Bronchial Asthma)
01/2013
1Inflammation (Inflammations)
01/2013
1Severe Acute Respiratory Syndrome
11/2003
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2002
1Bronchiectasis
12/2002
1Adenocarcinoma
12/2002

Drug/Important Bio-Agent (IBA)

1Transaminases (Aminotransferases)IBA
10/2018
1CrizotinibIBA
10/2018
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
05/2016
1ErbB Receptors (EGF Receptor)IBA
11/2015
1DNA (Deoxyribonucleic Acid)IBA
11/2015
1Biomarkers (Surrogate Marker)IBA
01/2013
1Oxygen (Dioxygen)IBA
11/2003
1Cisplatin (Platino)FDA LinkGeneric
07/2003
1Docetaxel (Taxotere)FDA Link
07/2003
1Proteins (Proteins, Gene)FDA Link
12/2002
1retinoic acid receptor betaIBA
12/2002
1Death-Associated Protein KinasesIBA
12/2002

Therapy/Procedure

1Therapeutics
10/2020
1Drug Therapy (Chemotherapy)
10/2018
1CT protocol
12/2002